Search clinical trials for: Glabellar lines of moderate severity at maximum frown
Total 457665 results
-
NEMA Research, Inc.RecruitingPain, PostoperativeUnited States
-
Assistance Publique - Hôpitaux de ParisGustave Roussy, Cancer Campus, Grand ParisNot yet recruitingMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Old Age | Severe/Moderate CoronavirusFrance
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
Parc Sanitari Pere VirgiliConsorci Sanitari Integral; Vall d'Hebron Institute of Research; Health and Ageing... and other collaboratorsRecruitingPatients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points)Spain, Sweden
-
AbbVieCompletedGlabellar LinesUnited States, Puerto Rico
-
AbbVieCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
Daewoong Pharmaceutical Co. LTD.Completed
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Daewoong Pharmaceutical Co. LTD.CompletedGlabellar LinesKorea, Republic of
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Galderma R&DCompletedGlabellar Frown LinesGermany, United Kingdom
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
-
AllerganCompleted
-
University of Southern CaliforniaActive, not recruitingGlabellar Frown LinesUnited States
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
AllerganCompleted
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
Evolus, Inc.ethica Clinical Research Inc.CompletedGlabellar Frown LinesUnited States
-
AllerganCompleted
-
IpsenTerminatedModerate Upper Facial Lines | Severe Upper Facial LinesGermany
-
Galderma R&DCompletedLateral Canthal Lines | Glabellar LinesUnited States, Puerto Rico
-
Merz North America, Inc.TerminatedGlabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper FaceUnited States
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Revance Therapeutics, Inc.CompletedFrown LinesUnited States, Canada
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
IpsenCompleted
-
BMI KoreaCompletedGlabellar LinesKorea, Republic of
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Mohamed Hayder Oleish SalihCompletedGlabellar Frown Lines | Wrinkle | Facial Expression | RhytidesEgypt
-
Galderma R&DCompleted
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
HugelCompletedGlabellar LinesKorea, Republic of
-
Croma-Pharma GmbHCompletedGlabellar Frown Lines
-
Croma-Pharma GmbHCompletedGlabellar Frown Lines
-
Nantes University HospitalTerminated
-
Iran University of Medical SciencesWithdrawnThyroid Eye DiseaseIran, Islamic Republic of
-
SolAeroMed Inc.SuspendedCovid19 | SARS-CoV-2 InfectionCanada
-
Croma-Pharma GmbHCompletedGlabellar Frown LinesUnited States
-
Clinical Research Center of the CarolinasPfizerCompleted
-
Merz Pharmaceuticals GmbHCompletedGlabellar LinesUnited States, Germany, Canada
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Istanbul Gelisim UniversityCompleted
-
Medy-ToxCompletedGlabellar Frown LinesKorea, Republic of
-
BayerCompletedDysmenorrheaUnited States
-
AllerganCompletedGlabellar Frown Lines | Facial RhytidesCanada
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States